Pfizer eyes emergency use approval for vaccine in November

This post was originally published on this site

The U.S. Food and Drug Administration has said it wants at least two months of safety data before authorizing emergency use of any experimental coronavirus vaccine.

Based on current trial enrollment and dosing pace, Pfizer expects to have that safety data in the third week of November, Chief Executive Officer Albert Bourla said in a statement.

Pfizer had said previously that it expected late-stage trial data in October. (https://